[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336727-105":59,"doc-detail-336727-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","somatic-mutations-in-3929-hpv-positive-cervical-cells-associated-with-infection-outcome-and-hpv-type","Somatic mutations in 3929 HPV-positive cervical cells associated with infection outcome and HPV type","","Invasive cervical cancers caused by HPV show heterogeneous molecular patterns. This study analyzes detection timing and HPV type specificity of somatic mutations in 3929 HPV-positive exfoliated cervical cell samples collected during U.S. cervical screening, using deep targeted sequencing across invasive cancers, precancers, and HPV-positive controls. Hotspot mutations are rare in controls (2.6%) but enriched in precancers, especially glandular lesions (10.2%), and in cancers (25.7%). Hotspots vary by HPV type, with HPV18/45-positive cancers more likely to contain multiple hotspots, and variant allele fractions rise with disease stage; mutations are detectable up to 6 years before diagnosis. Results support feasibility of using exfoliated cervical cells for biomarker development.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/somatic-mutations-in-3929-hpv-positive-cervical-cells-associated-with-infection-outcome-and-hpv-type/336727/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/somatic-mutations-in-3929-hpv-positive-cervical-cells-associated-with-infection-outcome-and-hpv-type/336727.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What samples and sequencing approach were used to study somatic mutations?","Question",{"text":112,"@type":113},"The study uses deep targeted sequencing on 3929 HPV-positive exfoliated cervical cell samples from individuals undergoing cervical screening. Samples include invasive cancers, precancers, and HPV-positive controls.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do hotspot mutations differ between controls, precancers, and invasive cancers?",{"text":117,"@type":113},"Hotspot mutations are uncommon in controls (2.6%) but significantly enriched in precancers, especially glandular precancer lesions (10.2%), and further increased in cancers (25.7%).",{"name":119,"@type":110,"acceptedAnswer":120},"Do hotspot mutations depend on HPV type and when can they be detected?",{"text":121,"@type":113},"Yes. Hotspot mutation patterns differ by HPV type, and HPV18/45-positive cancers are more likely to have multiple hotspot mutations than HPV16-positive cancers. The proportion of cells carrying hotspot mutations is higher in invasive cancer, and mutations can be detected up to 6 years before cancer diagnosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336727,1790619640,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article [https://doi.org/10.1038/s41467-024-51713-y](https://doi.org/10.1038/s41467-024-51713-y)  \nSomatic mutations in 3929 HPV positive cervical cells associated with infection outcome and HPV type  \nReceived: 5 December 2023  \n\n| Accepted: 13 August 2024 |\n| --- |\n| |\n| Check for updates |\n\nMaisa Pinheiro1, Nicolas Wentzensen1, Michael Dean 1,2, Meredith Yeager 1,2,3, Zigui Chen4, Amulya Shastry 1,2, Joseph F. Boland1,2, Sara Bass1,2,  \nLaurie Burdett1,2, Thomas Lorey5, Sambit Mishra 1,2, Philip E. Castle1,6,  \nMark Schiffman1, Robert D. Burk 7,8, Bin Zhu 1,9 & Lisa Mirabello 1,9   \nInvasive cervical cancers (ICC), caused by HPV infections, have a heterogeneous molecular landscape. We investigate the detection, timing, and HPV type speciﬁcity of somatic mutations in 3929 HPV-positive exfoliated cervical cell samples from individuals undergoing cervical screening in the U.S. using deep targeted sequencing in ICC cases, precancers, and HPV-positive controls. We discover a subset of hotspot mutations rare in controls (2.6%) but signiﬁcantly more prevalent in precancers, particularly glandular precancer lesions (10.2%), and cancers (25.7%), supporting their involvement in ICC carcinogenesis. Hotspot mutations differ by HPV type, and HPV18/45-positive ICC are more likely to have multiple hotspot mutations compared to HPV16-positive ICC. The proportion of cells containing hotspot mutations is higher (i.e., higher variant allele fraction) in ICC and mutations are detectable up to 6 years prior to cancer diagnosis. Our ﬁndings demonstrate the feasibility of using exfoliated cervical cells for detection of somatic mutations as potential diagnostic biomarkers.  \nInvasive cervical cancer (ICC) is the fourth most common cancer worldwide1 and virtually all cases are caused by an infection with oneof the 13 high-risk (HR) human papillomavirus (HPV) types2. The natural history of HPV leading to ICC is well-established, mostly based on HPV16 and squamous cell carcinoma (SCC), and is characterized by amultistage disease model that starts with HPV infection, that is persistently detectable over time when not controlled by the immune system2. These persistent infections often lead to the development of precancerous lesions that grow within the epithelium, often for years, that eventually can invade the surrounding tissue to become ICC2. The  \nnatural history of adenocarcinoma (ADC), the second most common histologic subtype, remains poorly understood.  \nThe cancer genome atlas (TCGA) project has identiﬁed driver mutations that presumably lead to ICC3,4. However, ICC is a heterogeneous disease with distinct somatic mutation spectrums related to SCC and ADC histologies4. Recurrent somatic mutations in PIK3CA, FBXW7, MAPK1, PTEN, EP300, NFE2L2, CASP8, STK11, HLA-A, and HLA-Bare enriched in SCC, while in ADC, ELF3, CBFB, KRAS and ARID1A are enriched4,5. One study also noted that the epigenomic and transcriptomic landscape of ICC differed by HPV species groups (Alpha 9  \n1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. 2Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick, MD, USA. 3Department of Biology, Hood College, Frederick, MD, USA. 4Department of Microbiology, The Chinese University of Hong Kong, Hong Kong, China. 5Regional Laboratory and Women’s Health Research Institute, Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA. 6Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. 7Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. 8Department of Obstetrics & Gynecology and Women’s Health, Albert Einstein College of Medicine, Bronx, NY, USA. 9These authors contributed equally: Bin Zhu, Lisa Mirabello.  \n [e-mail:](e-mail: mirabellol@mail.nih.gov)[ mirabellol@mail.nih.gov](e-mail: mirabellol@mail.nih.gov)  \nFig","cbCaig1bljwcNYwT","https://ap.wps.com/l/cbCaig1bljwcNYwT","pdf",1274525,12,"English","# Introduction\n## HPV-driven cervical carcinogenesis and heterogeneity\n## Prior driver mutations and mutational hotspots by histology\n# Methods\n## Deep targeted sequencing of exfoliated cervical cells\n## TIER mutation filtering and classification\n# Results\n## Enrichment of hotspot mutations across controls, precancers, and cancers\n## HPV-type specificity of hotspot patterns\n## Temporal detection prior to cancer diagnosis\n# Discussion\n## Exfoliated cells as a source for somatic mutation biomarkers","[{\"question\":\"What samples and sequencing approach were used to study somatic mutations?\",\"answer\":\"The study uses deep targeted sequencing on 3929 HPV-positive exfoliated cervical cell samples from individuals undergoing cervical screening. Samples include invasive cancers, precancers, and HPV-positive controls.\"},{\"question\":\"How do hotspot mutations differ between controls, precancers, and invasive cancers?\",\"answer\":\"Hotspot mutations are uncommon in controls (2.6%) but significantly enriched in precancers, especially glandular precancer lesions (10.2%), and further increased in cancers (25.7%).\"},{\"question\":\"Do hotspot mutations depend on HPV type and when can they be detected?\",\"answer\":\"Yes. Hotspot mutation patterns differ by HPV type, and HPV18/45-positive cancers are more likely to have multiple hotspot mutations than HPV16-positive cancers. The proportion of cells carrying hotspot mutations is higher in invasive cancer, and mutations can be detected up to 6 years before cancer diagnosis.\"}]","Somatic mutations in 3929 HPV-positive cervical cells associated with infection outcome and HPV type | PDF",1790016377,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d472a0a50d1b238c4824b82cba1e3ac.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/226dc70e4bbd430284db1ecca3c48d2b.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a3ad0ec4ffdc3e6132e3284c36e4b90.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ff45d5d017099fee13212f358a1df91.webp",980,1301]